PEN | tickerfilter.com

Fundamental analysis

19%

Profitability 16%

Dept financing 26%

Liquidity 58%

Performance 10%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-3.71%

1 Month

16.89%

3 Months

7.61%

6 Months

-12.32%

1 Year

-23.35%

2 Year

25.07%

Key data

Stock price

$202.32

P/E Ratio

552.12

DAY RANGE

$199.86 - $203.84

EPS

$0.36

52 WEEK RANGE

$148.00 - $302.00

52 WEEK CHANGE

-$0.23

MARKET CAP

7.859 B

YIELD

N/A

SHARES OUTSTANDING

38.844 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

0.93

PUBLIC FLOAT

AVERAGE 10 VOLUME

$428,368

AVERAGE 30 VOLUME

$487,204

Company detail

CEO: Adam Elsesser
Region: US
Website: http://www.penumbrainc.com/
Employees: 2,391
IPO year: -

Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. we design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. today we have over 1,000 employees with sales operations in north america, europe, australia and asia.

PEN - Penumbra Inc